UPDATE 1-Bristol-Myers beats Wall St estimates, helped by cancer drug Opdivo
April 27, 2017 at 10:34 AM EDT
NEW YORK, April 27 (Reuters) - Bristol-Myers Squibb Co on Thursday reported higher-than-expected quarterly earnings, helped by increased sales of cancer drugs Opdivo and Yervoy and blood thinner Eliquis.
